相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy
Carmen M. Montagnon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
Carmen M. Montagnon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
Dedee F. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wanying Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany
Franziska Huebner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis
Lihi Atzmony et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients
K. D. Tran et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids
Naif Almugairen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris
Sharon Baum et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2012)
Prevention and treatment of systemic glucocorticoid side effects
Siamak Moghadam-Kia et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid
H. M. Guercan et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee E. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Suggested guidelines for patient monitoring: Hepatic and hematologic toxicity attributable to systemic dermatologic drugs
Stephen E. Wolverton et al.
DERMATOLOGIC CLINICS (2007)